Paris - Delayed Quote EUR
MedinCell S.A. (MEDCL.PA)
14.93
-0.54
(-3.49%)
At close: 5:35:27 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | -0.37 | 0.81 |
| Low Estimate | 0 | 0 | -0.67 | 0.07 |
| High Estimate | 0 | 0 | -0.07 | 1.55 |
| Year Ago EPS | -- | -- | -0.88 | -0.37 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 4 |
| Avg. Estimate | 5.1M | 5.7M | 20.13M | 39.65M |
| Low Estimate | 5.1M | 5.7M | 13.2M | 28.5M |
| High Estimate | 5.1M | 5.7M | 25M | 48M |
| Year Ago Sales | -- | -- | 9.03M | 20.13M |
| Sales Growth (year/est) | -- | -- | 122.92% | 96.93% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.37 | 0.81 |
| 7 Days Ago | 0 | 0 | -0.37 | 0.81 |
| 30 Days Ago | 0 | 0 | -0.37 | 0.81 |
| 60 Days Ago | 0 | 0 | -0.37 | 0.81 |
| 90 Days Ago | 0 | 0 | -0.41 | 0.92 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | -- |
| Up Last 30 Days | -- | -- | 2 | -- |
| Down Last 7 Days | -- | -- | -- | 2 |
| Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MEDCL.PA | -- | -- | 57.95% | 318.92% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Related Tickers
TGNA.F Transgene SA
0.5780
+1.40%
IPH.PA Innate Pharma S.A.
1.9200
-1.64%
ADOC.PA Adocia SA
4.5250
-13.65%
DBV.PA DBV Technologies S.A.
1.9900
-12.33%
VLA.PA Valneva SE
2.8020
-3.04%
1177.HK SINO BIOPHARM
3.900
-2.50%
CLRB Cellectar Biosciences, Inc.
0.2456
+2.04%
LPCN Lipocine Inc.
3.4100
+7.91%
CRBP Corbus Pharmaceuticals Holdings, Inc.
6.94
-1.42%
GNPX Genprex, Inc.
0.2344
+5.11%